4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-012250
Chief Executive Officer sold 5,122 shares at $6.63 ($33,935)
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-21 | Sale : show line 1 in the form | −5,122 | $6.63 | $33,935 | 929,572 | D |
| Open-market sales · 5,122 sh · avg $6.63 · $33,935 | ||||||
Loading xslF345X03/doc4.xml…